| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 170232-37-8 | 3-Acetoxy-5-chloro-1-(4-fluorophenyl)-1H-indole | C16H11ClFNO2 |
| 170235-26-4 | Methyl 2-bromothiazole-4-carboxylate | C5H4BrNO2S |
| 170245-12-2 | Melanotropin B (Petromyzon marinus) | C107H157N33O29S |
| 170245-18-8 | 3H-Imidazo[4,5-b]pyridine | C6H5N3 |
| 170275-23-7 | 2-Ethylhexanoic acid triethylmethylammonium salt | C8H15O2.C7H18N |
| 170277-31-3 | Infliximab | |
| 170298-33-6 | 9-[[O-2-(Acetylamino)-2-deoxy-alpha-D-galactopyranosyl-(1→3)-O-[6-deoxy-alpha-L-galactopyranosyl-(1→2)]-alpha-D-galactopyranosyl]oxy]-N-(2-aminoethyl)nonanamide | C31H57N3O16 |
| 170355-38-1 | Ethyl 5-bromothiophene-3-carboxylate | C7H7BrO2S |
| 170364-57-5 | Enzastaurin | C32H29N5O2 |
| 170364-89-3 | 4-(1H-Indol-1-yl)-1-piperidinecarboxylic acid tert-butyl ester | C18H24N2O2 |
| 170367-69-8 | (R)-3-Boc-aminobutylamine | C9H20N2O2 |
| 170384-29-9 | (2-Oxopropyl)carbamic acid tert-butyl ester | C8H15NO3 |
| 170384-75-5 | Isohyperectine | C24H21N3O6 |
| 170428-84-9 | 2'-Deoxyuridine 5'-[hydrogen [[hydroxy(phosphonooxy)phosphinyl]methyl]phosphonate] | C10H17N2O13P3 |
| 170428-86-1 | 2'-Deoxyuridine 5'-(P,P',P'',P''-tetrahydrogen imidotriphosphate) | C9H16N3O13P3 |
| 170434-11-4 | 4-Bromo-2-hydroxybenzyl alcohol | C7H7BrO2 |
| 170449-18-0 | N-(3-Chlorophenyl)-6,7-dimethoxy-4-quinazolinamine hydrochloride | C16H14ClN3O2.HCl |
| 170487-38-4 | Methyl 4-oxazolecarboxylate | C5H5NO3 |
| 170487-40-8 | Methyl 1H-indazole-6-carboxylate | C9H8N2O2 |
| 170491-63-1 | tert-Butyl 2-(hydroxymethyl)pyrrolidine-1-carboxylate | C10H19NO3 |
| 170492-47-4 | 1-Hydroxy-6-methylsulfonylindole | C9H9NO3S |
| 170505-38-1 | [S-(R*,R*)]-2-(2-Fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol | C12H14FN3O2 |
| 170505-39-2 | [S-(R*,R*)]-2-(4-Fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-2,3-butanediol | C12H14FN3O2 |
| 170564-98-4 | (R)-3-Amino-3-phenylpropan-1-ol | C9H13NO |
| 170569-87-6 | 4-(5-Phenyl-3-trifluoromethyl-1H-pyrazol-1-yl)benzenesulfonamide | C16H12F3N3O2S |
| 170569-88-7 | Mavacoxib | C16H11F4N3O2S |
| 170569-93-4 | 4-[5-(4-Bromophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide | C16H11BrF3N3O2S |
| 170569-99-0 | 4-[5-(2-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide | C17H14F3N3O2S |
| 170570-01-1 | 4-[5-(3-Methylphenyl)-3-trifluoromethyl-1H-pyrazol-1-yl]benzenesulfonamide | C17H14F3N3O2S |
| 170570-09-9 | 4-[5-(2,4-Dimethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide | C18H16F3N3O2S |
| 170570-75-9 | 4-[5-[4-(Bromomethyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide | C17H13BrF3N3O2S |
| 170571-00-3 | 4-[5-(4-Hydroxymethylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzenesulfonamide | C17H14F3N3O3S |
| 170571-01-4 | 4-[1-[4-(Aminosulfonyl)phenyl]-3-(trifluoromethyl)-1H-pyrazol-5-yl]benzoic acid | C17H12F3N3O4S |
| 170572-38-0 | 2,5,8,11,14,17,20-Heptaoxadocosan-22-amine | C15H33NO7 |
| 170572-47-1 | 3,5-Difluoro-4-hydroxybenzoic acid methyl ester | C8H6F2O3 |
| 170572-48-2 | 1,3-Difluoro-2-methyl-5-nitrobenzene | C7H5F2NO2 |
| 170572-49-3 | 3-Fluoro-4-methylbenzonitrile | C8H6FN |
| 170572-50-6 | 3,5-Difluoro-4-methylbenzonitrile | C8H5F2N |
| 170572-51-7 | 5-Chloro-1,3-difluoro-2-methoxybenzene | C7H5ClF2O |
| 170621-86-0 | 4-Chloro-3-methoxypyridine-2-carboxylic acid | C7H6ClNO3 |
| 170632-47-0 | Lificiguat | C19H16N2O2 |
| 170638-05-8 | (R)-7-Methoxy-1,2,3,4-tetrahydronaphthalen-2-ylamine hydrochloride | C11H15NO.HCl |
| 170642-27-0 | Fmoc-D-2-aminobutyric acid | C19H19NO4 |
| 170642-28-1 | (R)-N-Fmoc-Allylglycine | C20H19NO4 |
| 170642-29-2 | Fmoc-D-Cyclopropylalanine | C21H21NO4 |
| 170642-31-6 | (R)-2-Amino-3-(2-methoxyphenyl)propanoic acid | C10H13NO3 |
| 170643-02-4 | O-(tert-Butyl)-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-D-allothreonine | C23H27NO5 |
| 170655-44-4 | 2-Chloro-N-(2,2,2-trifluoroethyl)acetamide | C4H5ClF3NO |
| 170655-69-3 | L-Leucyl-L-glutaminyl-L-valyl-L-glutaminyl-L-leucyl-L-seryl-L-isoleucyl-L-arginine | C42H77N13O12 |
| 170681-91-1 | 5-Bromo-7-methylbenzofuran | C9H7BrO |